Filter by
Medicinal products - Consultations (73)
RSSShowing results 1 to 20
- Status: Closed
Targeted stakeholder consultation on the amendments to Commission Implementing Regulation (EU) 520/2012 on pharmacovigilance activities
- Opening date
- Deadline
- Status: Closed
Impact assessment – EU legislation on medicines for rare diseases and paediatric medicines
- Opening date
- Deadline
- Status: Closed
Targeted stakeholder consultation on the pilot project ‘Market Launch Intentions of Centrally Authorised Products’
- Opening date
- Deadline
- Status: Closed
Targeted stakeholders' consultation on Annex 21: Importation of medicinal products, of the Eudralex volume 4
- Opening date
- Deadline
- Status: Closed
Public consultation on legislation on medicines for children and rare diseases
- Opening date
- Deadline
- Status: Closed
Targeted stakeholder consultation on the draft Guidelines on Good Clinical Practice for Advanced Therapy Medicinal Products
- Opening date
- Deadline
- Status: Closed
Targeted stakeholder consultation on duplicate marketing authorisations for biological medicinal products
- Opening date
- Deadline
- Status: Closed
Study supporting the Evaluation of the European Medicines Agency Fee System
- Opening date
- Deadline
- Status: Closed
Targeted stakeholders consultation on the revision of annex 1, on manufacturing of sterile medicinal products, of the Eudralex volume 4
- Opening date
- Deadline
- Status: Closed
Targeted stakeholder consultation on the experience acquired with the Paediatric Regulation
- Opening date
- Deadline
- Status: Closed
Public consultation on the concept of "similar medicinal product" in the context of the orphan legislation
- Opening date
- Deadline
- Status: Closed
Targeted stakeholder consultation on the draft Guidelines on Good Manufacturing Practice for Advanced Therapy Medicinal Products
- Opening date
- Deadline